ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,509.01
0.62%
Dow Jones
39,331.85
0.41%
US Dollar vs MXN
18.26509
-0.01%
Brent Oil
86.335
-0.13%
Bitcoin
60,847.48
-1.90%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Aptevo Therapeutics Inc (APVO)

  7. Aptevo Therapeutics Inc (APVO) Noticias

APVO

Aptevo Therapeutics (APVO)

Aptevo Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:APVO
FechaHoraFuenteTítuloSímboloCompañía
14/06/202415:30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:APVOAptevo Therapeutics Inc
10/06/202415:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
03/06/202415:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
08/05/202407:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APVOAptevo Therapeutics Inc
05/03/202407:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:APVOAptevo Therapeutics Inc
30/01/202407:00Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:APVOAptevo Therapeutics Inc
22/12/202315:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:APVOAptevo Therapeutics Inc
12/12/202315:19Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:APVOAptevo Therapeutics Inc
30/11/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:APVOAptevo Therapeutics Inc
22/11/202315:05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:APVOAptevo Therapeutics Inc
03/08/202316:21Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:APVOAptevo Therapeutics Inc
01/08/202315:01Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:APVOAptevo Therapeutics Inc
02/06/202315:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APVOAptevo Therapeutics Inc
02/06/202315:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APVOAptevo Therapeutics Inc
19/04/202307:32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:APVOAptevo Therapeutics Inc
18/04/202307:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:APVOAptevo Therapeutics Inc
30/03/202307:03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:APVOAptevo Therapeutics Inc
07/03/202315:44Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:APVOAptevo Therapeutics Inc
07/03/202315:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APVOAptevo Therapeutics Inc
14/02/202309:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APVOAptevo Therapeutics Inc
12/12/202209:33TipRanksAptevo Skyrockets on Promising Clinical DataNASDAQ:APVOAptevo Therapeutics Inc
10/11/202207:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APVOAptevo Therapeutics Inc
30/03/202207:31Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:APVOAptevo Therapeutics Inc
29/03/202206:56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:APVOAptevo Therapeutics Inc
22/11/202116:29Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APVOAptevo Therapeutics Inc
02/11/202108:00GlobeNewswire Inc.BriaCell Appoints Renowned Pharmaceutical Veteran Jane Gross, Ph.D. to its Board of DirectorsNASDAQ:APVOAptevo Therapeutics Inc
20/08/202105:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APVOAptevo Therapeutics Inc
11/05/202107:56Edgar (US Regulatory)Proxy Statment - Contested Solicitations (definitive) (defc14a)NASDAQ:APVOAptevo Therapeutics Inc
28/04/202115:21Edgar (US Regulatory)Proxy Statement - Contested Solicitations (preliminary) (prec14a)NASDAQ:APVOAptevo Therapeutics Inc
28/04/202115:19Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:APVOAptevo Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:APVO

Su Consulta Reciente

USOTC
ADDYY
Adidas (QX)
NYSE
NKE
Nike
AMEX
XLE
Energy Select Sector SPDR
NYSE
KO
Coca Cola
NYSE
VZ
Verizon Communications
FX
USDMXN
US Dollar vs MXN
CCOM
US30
US 30
USOTC
BASFY
BASF (QX)
SPI
SP500
S&P 500
CCOM
SILVER
SILVER
NASDAQ
AAPL
Apple
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
SPY
SPDR S&P 500
NYSE
MRK
Merck
USOTC
DTEGY
Deutsche Telekom (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados